Grants Search Results
Need help? Call us at (888) 899-2253
Interested in applying for a St. Baldrick's Foundation grant? Learn more about the grant application process.
Showing 1081-1100 of 2435 results
The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015
through 06-30-2022
Funding Type: Consortium Research Grant
Institution Location:
Toronto, ON
Institution: Sunnybrook Health Sciences Centre
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015
through 06-30-2022
Funding Type: Consortium Research Grant
Institution Location:
Lyon, France
Institution: Institut D'Hematologie et D'Oncologie Pediatrique
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015
through 06-30-2022
Funding Type: Consortium Research Grant
Institution Location:
New York, NY
Institution: Memorial Sloan Kettering Cancer Center
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015
through 06-30-2022
Funding Type: Consortium Research Grant
Institution Location:
Villejuif, France
Institution: Institut Gustave Roussy
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015
through 06-30-2022
Funding Type: Consortium Research Grant
Institution Location:
Houston, TX
Institution: University of Texas M.D. Anderson Cancer Center
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015
through 06-30-2022
Funding Type: Consortium Research Grant
Institution Location:
Camperdown, Australia
Institution: Chris O'Brien Lifehouse
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015
through 06-30-2022
Funding Type: Consortium Research Grant
Institution Location:
Newcastle, United Kingdom
Institution: The Newcastle upon Tyne Hospital
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015
through 06-30-2022
Funding Type: Consortium Research Grant
Institution Location:
Sutton, United Kingdom
Institution: The Institute of Cancer Research
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015
through 06-30-2022
Funding Type: Consortium Research Grant
Institution Location:
Evanston, IL
Institution: NorthShore University Health System
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015
through 06-30-2022
Funding Type: Consortium Research Grant
Institution Location:
Cairo, Egypt
Institution: Children's Cancer Hospital Egypt
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015
through 06-30-2022
Funding Type: Consortium Research Grant
Institution Location:
Seattle, WA
Institution: Virginia Mason Medical Center
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015
through 06-30-2022
Funding Type: Consortium Research Grant
Institution Location:
Barretos, Brazil
Institution: Hospital de Cancer de Barretos
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015
through 06-30-2022
Funding Type: Consortium Research Grant
Institution Location:
Cambridge, United Kingdom
Institution: Cambridge University Hospitals
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015
through 06-30-2022
Funding Type: Consortium Research Grant
Institution Location:
Atlanta, GA
Institution: Emory University
affiliated with Children's Healthcare of Atlanta, Children's Healthcare of Atlanta at Egleston, Aflac Cancer Center
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015
through 06-30-2022
Funding Type: Consortium Research Grant
Institution Location:
New Haven, CT
Institution: Yale University
affiliated with Yale-New Haven Children's Hospital
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015
through 06-30-2022
Funding Type: Consortium Research Grant
Institution Location:
Los Angeles, CA
Institution: University of Southern California
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015
through 06-30-2022
Funding Type: Consortium Research Grant
Institution Location:
Toronto, ON
Institution: Hospital for Sick Children
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015
through 06-30-2022
Funding Type: Consortium Research Grant
Institution Location:
Leeds, United Kingdom
Institution: University of Leeds
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
The Malignant Germ Cell Tumor International Consortium (MaGIC) member
Funded: 07-01-2015
through 06-30-2022
Funding Type: Consortium Research Grant
Institution Location:
London, United Kingdom
Institution: University College London Hospitals
This institution is a member of a research consortium which is being funded by St. Baldrick's: The Malignant Germ Cell Tumor International Consortium (MaGIC). For a description of this project, see the consortium grant made to the lead institution: Dana-Farber Cancer Institute, Boston, MA.
Christopher French M.D.
Funded: 07-01-2015
through 06-30-2016
Funding Type: Research Grant
Institution Location:
Boston, MA
Institution: Brigham and Women's Hospital, Inc.
Dr. French's research focuses on a deadly cancer of children and young adults called NUT midline carcinoma. A while back Dr. French discovered the cancer protein that causes this disease, called BRD4-NUT. This discovery led to the development of inhibitors to BRD4 that are now being used to treat NUT midline carcinoma and this has expanded to the treatment of more common cancers in clinical trials. However, NUT midline carcinoma remains incurable. Recently, Dr. French discovered an additional and completely new protein that associates with BRD4-NUT, called a ZNF532, that helps BRD4-NUT cause this cancer. This research aims to understand how this new cancer protein contributes to the malignancy in this disease.